HK1192417A1 - 類薑黃色素固體分散物配方 - Google Patents

類薑黃色素固體分散物配方

Info

Publication number
HK1192417A1
HK1192417A1 HK14101705.8A HK14101705A HK1192417A1 HK 1192417 A1 HK1192417 A1 HK 1192417A1 HK 14101705 A HK14101705 A HK 14101705A HK 1192417 A1 HK1192417 A1 HK 1192417A1
Authority
HK
Hong Kong
Prior art keywords
solid dispersion
dispersion formulation
curcuminoid
curcuminoid solid
formulation
Prior art date
Application number
HK14101705.8A
Other languages
English (en)
Inventor
Jrg Breitenbach
Thomas K Kessler
Katrin Schneider
Tapas Das
Shreeram Sathya
Ai Mey Chuah
Gaurav C Patel
Original Assignee
Abbott Gmbh & Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Gmbh & Co Kg filed Critical Abbott Gmbh & Co Kg
Publication of HK1192417A1 publication Critical patent/HK1192417A1/zh

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/12Ketones
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105Plant extracts, their artificial duplicates or their derivatives
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L5/00Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
    • A23L5/20Removal of unwanted matter, e.g. deodorisation or detoxification
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pulmonology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HK14101705.8A 2010-10-14 2014-02-21 類薑黃色素固體分散物配方 HK1192417A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US39320610P 2010-10-14 2010-10-14
PCT/EP2011/067901 WO2012049253A1 (en) 2010-10-14 2011-10-13 Curcuminoid solid dispersion formulation

Publications (1)

Publication Number Publication Date
HK1192417A1 true HK1192417A1 (zh) 2014-08-22

Family

ID=44907819

Family Applications (1)

Application Number Title Priority Date Filing Date
HK14101705.8A HK1192417A1 (zh) 2010-10-14 2014-02-21 類薑黃色素固體分散物配方

Country Status (11)

Country Link
US (1) US20130303628A1 (zh)
EP (1) EP2627195B1 (zh)
JP (1) JP2014503470A (zh)
CN (1) CN103237458A (zh)
BR (1) BR112013008737A2 (zh)
CA (1) CA2813510A1 (zh)
ES (1) ES2511145T3 (zh)
HK (1) HK1192417A1 (zh)
MX (1) MX2013004160A (zh)
SG (1) SG189403A1 (zh)
WO (1) WO2012049253A1 (zh)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2494733C1 (ru) * 2012-10-16 2013-10-10 Всеволод Иванович Киселев Фармацевтическая композиция на основе фитонутриентов с повышенной биодоступностью, обладающая противоопухолевой активностью, и способ ее получения (варианты)
TWI660680B (zh) 2012-11-26 2019-06-01 美商通路實業集團國際公司 抗氧化膳食增補劑及其相關方法
US20150296867A1 (en) 2012-12-14 2015-10-22 Abbott Laboratories Methods for extruding powered nutritional products using a high shear element
JP6150518B2 (ja) * 2012-12-27 2017-06-21 花王株式会社 ポリフェノール組成物の製造方法
US20150374024A1 (en) 2013-03-12 2015-12-31 Abbott Laboratories Microbial reduction in nutritional product using an extrusion process
MY195405A (en) 2013-03-13 2023-01-19 Abbott Lab Method of Enhancing Bioavailability of DHA and Other Lipid-Soluble Nutrients
US9504754B2 (en) * 2013-03-15 2016-11-29 South Dakota Board Of Regents Curcuminoid complexes with enhanced stability, solubility and/or bioavailability
CN104739751B (zh) * 2013-12-26 2018-11-20 四川省中医药科学院 一种四氢姜黄素固体分散体及其制备方法
CA2945587A1 (en) * 2014-04-18 2015-10-22 Omniactive Health Technologies Limited Curcumin compositions and uses thereof
WO2015174475A1 (ja) * 2014-05-15 2015-11-19 株式会社セラバリューズ 経口摂取用組成物
WO2016010093A1 (ja) * 2014-07-16 2016-01-21 株式会社セラバリューズ 非晶質クルクミン及び/又はその類縁体を含有する複合体の製造方法
WO2016031651A1 (ja) * 2014-08-29 2016-03-03 花王株式会社 難溶解性ポリフェノール類を含有する固体分散体の製造方法
ES2960344T3 (es) 2015-03-10 2024-03-04 Shionogi Inc Dispersiones sólidas que comprenden ospemifeno
WO2016183134A1 (en) * 2015-05-12 2016-11-17 Cutting Edge Medical Solutions, Llc Palmitoylethanolamide compositions
US10709672B2 (en) * 2015-10-09 2020-07-14 San-Ei Gen F.F.I., Inc. Polyphenol-containing solid composition
JP2017137294A (ja) * 2016-01-29 2017-08-10 静岡県公立大学法人 ショウガ科植物抽出物送達用組成物
CN107308133A (zh) * 2016-04-27 2017-11-03 周意 姜黄素药物制剂
GB201608276D0 (en) * 2016-05-11 2016-06-22 Abbott Lab Additive for a nutritional composition
US20190380976A1 (en) * 2017-03-03 2019-12-19 San-Ei Gen F.F.I., Inc. Curcumin-containing medicinal preparation and method for evaluating absorption or elution characteristics thereof
WO2018159852A1 (ja) * 2017-03-03 2018-09-07 三栄源エフ・エフ・アイ株式会社 クルクミン含有製剤
WO2019019091A1 (zh) * 2017-07-27 2019-01-31 周意 姜黄素药物制剂
US20190038754A1 (en) * 2017-08-07 2019-02-07 SE Tylose, USA, Inc. Pharmaceutical composition in solid extruded form
CN111726992B (zh) * 2018-02-19 2024-02-23 热值株式会社 口服摄取用组合物
GB2591679B (en) * 2018-09-26 2023-06-07 Inventia Healthcare Ltd Curcuminoid composites
CN109350610B (zh) * 2018-12-12 2021-06-01 湖南湘源美东医药科技有限公司 一种姜黄素复合纳米颗粒及其制备方法
KR102062791B1 (ko) * 2019-02-26 2020-01-06 신일제약 주식회사 미라베그론 또는 그의 약제학적으로 허용되는 염을 함유한 방출조절 제제
IT201900003907A1 (it) * 2019-03-18 2020-09-18 Indena Spa Composizioni comprendenti curcumina e coenzima q10
BE1027067B1 (fr) * 2019-06-28 2020-09-11 Tilman Sa Composition comprenant de la curcumine
JP2021042173A (ja) * 2019-09-12 2021-03-18 株式会社ファンケル クルクミン固体分散体
AU2020398079B2 (en) * 2019-12-03 2024-09-19 Omniactive Health Technologies Limited Curcumin compositions for osteoarthritis and joint wellness
JP7080504B2 (ja) * 2020-05-08 2022-06-06 株式会社セラバリューズ クルクミン含有経口摂取用固形製剤
CN113652180B (zh) * 2021-08-23 2023-01-13 湖北中烟工业有限责任公司 一种添加姜黄素纳米颗粒的cmc-壳聚糖胶黏剂的制备方法
CN115998687B (zh) * 2022-11-04 2024-08-09 温州医科大学 一种姜黄素衍生物的固体分散体及其制备和应用
CN117379574B (zh) * 2023-10-13 2024-05-31 中国热带农业科学院农产品加工研究所 一种ε-聚赖氨酸联合姜黄素为介导的光动力灭菌方法

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07291854A (ja) * 1994-04-26 1995-11-07 Tanabe Seiyaku Co Ltd 溶解性の改善された医薬品製剤
TW487582B (en) * 1995-08-11 2002-05-21 Nissan Chemical Ind Ltd Method for converting sparingly water-soluble medical substance to amorphous state
DE19536394A1 (de) * 1995-09-29 1997-04-03 Basf Ag Feste Arzneiformen, erhältlich durch Extrusion einer Isomalt enthaltenden Polymer-Wirkstoff-Schmelze
HU227745B1 (en) * 1996-05-20 2012-02-28 Janssen Pharmaceutica Nv Antifungal compositions containing itraconazole
US6210701B1 (en) * 1999-04-30 2001-04-03 Healthcomm International, Inc. Medical food for treating inflammation-related diseases
AU779230C (en) 1999-12-03 2006-05-25 Emory University Curcumin analogues for treating cancer
DE10026698A1 (de) * 2000-05-30 2001-12-06 Basf Ag Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung
DE10038571A1 (de) * 2000-08-03 2002-02-14 Knoll Ag Zusammensetzungen und Dosierungsformen zur Anwendung in der Mundhöhle bei der Bhandlung von Mykosen
DE10247037A1 (de) * 2002-10-09 2004-04-22 Abbott Gmbh & Co. Kg Herstellung von festen Dosierungsformen unter Verwendung eines vernetzten nichtthermoplastischen Trägers
CA2509958A1 (en) * 2003-02-03 2004-08-19 Novartis Ag Pharmaceutical formulation
US7968115B2 (en) * 2004-03-05 2011-06-28 Board Of Regents, The University Of Texas System Liposomal curcumin for treatment of cancer
CN1274300C (zh) * 2003-12-11 2006-09-13 中国科学院生物物理研究所 用于改善姜黄素溶出度和生物利用度的药物组合物及其制备方法
WO2006022012A1 (ja) * 2004-08-27 2006-03-02 Ff Corporation Ltd. クルクミンの固形分散物及びその製造方法
US20060078617A1 (en) * 2004-08-27 2006-04-13 Fritz Schueckler Pharmaceutical compositions for the treatment of cancer
CN100340238C (zh) * 2005-06-09 2007-10-03 中山大学 姜黄素固体分散体及其制备方法与应用
EP1832281A1 (en) * 2006-03-10 2007-09-12 Abbott GmbH & Co. KG Process for producing a solid dispersion of an active ingredient
US9192644B2 (en) * 2006-03-06 2015-11-24 The Regents Of The University Of California Bioavailable curcuminoid formulations for treating Alzheimer's disease and other age-related disorders
WO2010010431A1 (en) 2008-07-24 2010-01-28 National Institute Of Pharmaceutical Education And Research Self-nano-emulsifying curcuminoids composition with enhanced bioavailability
CA2732635A1 (en) 2008-07-31 2010-02-04 Santosh Kumar Kar Curcumin nanoparticles and methods of producing the same
CN101361713B (zh) * 2008-09-08 2010-08-25 山东大学 姜黄素纳米结晶制剂的制备方法

Also Published As

Publication number Publication date
ES2511145T3 (es) 2014-10-22
JP2014503470A (ja) 2014-02-13
CN103237458A (zh) 2013-08-07
US20130303628A1 (en) 2013-11-14
MX2013004160A (es) 2013-08-29
CA2813510A1 (en) 2012-04-19
WO2012049253A1 (en) 2012-04-19
EP2627195B1 (en) 2014-08-20
BR112013008737A2 (pt) 2015-09-01
EP2627195A1 (en) 2013-08-21
SG189403A1 (en) 2013-05-31

Similar Documents

Publication Publication Date Title
HK1192417A1 (zh) 類薑黃色素固體分散物配方
ZA201301301B (en) Antimicrobial formulation
HK1189834A1 (zh) 基於固體分散體的固體延緩配方
EP2552212B8 (en) An improved formulation
EP2531023A4 (en) ENHANCED FORMULATION
ZA201206589B (en) Incotine containing formulation
HRP20170172T1 (hr) Farmaceutski pripravci s visokim doziranjem u biotinu
ZA201300194B (en) Formulations
GB201110193D0 (en) Formulations
GB201013513D0 (en) Formulations
GB201006326D0 (en) Formulation
ZA201300196B (en) Formulations
EP2566322A4 (en) PESTICIDE DISPERSION WITH NANOSTRUCTURED DISPERSED PHASE
GB201005992D0 (en) Formulation
GB201001978D0 (en) Formulation
GB201002000D0 (en) Formulation
PL2547208T3 (pl) Proszkowa kompozycja biocydu
GB201021512D0 (en) Dispersion anaeshetic device
ZA201102357B (en) Parasiticidal formulation
GB201018649D0 (en) Formulations
GB201018648D0 (en) Formulations
GB201018647D0 (en) Formulations
GB201018645D0 (en) Formulations
GB201012589D0 (en) Formulations
GB201010494D0 (en) Formulations

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20181013